
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 2.0% on an annualized basis producing an average annual return of 14.27%. Currently, Halozyme Therapeutics has a market capitalization of $6.64 billion. Buying $1000 In HALO: If ... Full story available on…
Full Article